<DOC>
	<DOC>NCT00086346</DOC>
	<brief_summary>The purpose of this study is to evaluate the sirolimus conversion regimen as compared with the calcineurin inhibitor continuation regimen with regards to renal function in stable liver transplant subjects.</brief_summary>
	<brief_title>Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Age greater than 13 years (age greater than 18 years as required by some local regulations). Receiving immunosuppressive therapy with calcineurin inhibitors (CI) +/ corticosteroids +/ antimetabolite. 6 to 144 months after orthotopic liver transplantation. CockcroftGault GFR values ≥40 mL/min and ≤90mL/min at screening History of nonhepatic transplantation Evidence of systemic infection (sepsis, bacteremia, pneumonia etc). Known or suspected malignancy &lt; 5 years before random assignment.</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Liver</keyword>
	<keyword>Transplant</keyword>
</DOC>